Data Collective IV GP, LLC

PALO ALTO, CA · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$63.3M2026 Q3
Positions4
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.100.0%

Data Collective IV GP, LLC reported 4 positions worth $63.3M as of September 30, 2026 (13F filed November 16, 2026). Largest holding: RXRX (38.8%).

4 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 RXRXRecursion Pharmaceuticals$24.5M38.76%5,941,120——-22.9%
▸ 2 EVLVEvolv Technologies$21.3M33.72%4,590,000——-16.1%
▸ 3 HQHorizon Quantum$13.6M21.48%915,198——-20.2%
▸ 4 DFTXDefinium Therapeutics$3.8M6.03%100,350——-15.7%

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Data Collective IV GP, LLC hold as of Q3 2026?

Data Collective IV GP, LLC reported 4 positions worth $63.3M in its Q3 2026 13F filing. Largest positions: RXRX (38.8%), EVLV (33.7%), HQ (21.5%) and DFTX (6.0%).

What did Data Collective IV GP, LLC buy in Q3 2026?

Data Collective IV GP, LLC opened or added to no positions in Q3 2026.

What did Data Collective IV GP, LLC sell in Q3 2026?

Data Collective IV GP, LLC reduced or sold out of no positions in Q3 2026.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.